Vera Therapeutics, Inc.

Healthcare

NASDAQ:VERA · NASDAQ Global Market

Market Cap $2.51B Beta 0.95 P/E (TTM) -6.8

$35.09 +0.27%

+$0.09 today

52W Low $19.07High $56.05

Vol 1.50M · Avg 1.18M

EPS (TTM) -$5.16Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+62.08%

Period High

$55.67

Period Low

$19.25

Latest

$35.09

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

uniQure N.V.

NASDAQ:QURE

$2.99B

Pharvaris N.V.

NASDAQ:PHVS

$2.30B

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$2.19B

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

$1.92B

Nuvation Bio Inc.

NYSE:NUVB

$1.89B

Immunome, Inc.

NASDAQ:IMNM

$1.75B

AbCellera Biologics Inc.

NASDAQ:ABCL

$1.66B

Viridian Therapeutics, Inc.

NASDAQ:VRDN

$1.50B

Biohaven Ltd.

NYSE:BHVN

$1.44B

Janux Therapeutics, Inc.

NASDAQ:JANX

$852.41M

What is the latest VERA filing?

The latest filing shown is 8-K dated Jun 2, 2026.

How many recent filings does VERA have?

Intrinsic Alpha currently shows 20 recent filings for VERA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.